BR9714642A - "uso de texafirina na preparação de um medicamento para uso em diagnóstico e terapia ocular" - Google Patents

"uso de texafirina na preparação de um medicamento para uso em diagnóstico e terapia ocular"

Info

Publication number
BR9714642A
BR9714642A BR9714642-0A BR9714642A BR9714642A BR 9714642 A BR9714642 A BR 9714642A BR 9714642 A BR9714642 A BR 9714642A BR 9714642 A BR9714642 A BR 9714642A
Authority
BR
Brazil
Prior art keywords
therapy
texaphyrin
eye
texaphyrins
texafirine
Prior art date
Application number
BR9714642-0A
Other languages
English (en)
Inventor
Mark S Blumenkranz
Kathryn W Woodburn
Richard A Miller
Stuart W Young
Original Assignee
Pharmacyclics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics Inc filed Critical Pharmacyclics Inc
Publication of BR9714642A publication Critical patent/BR9714642A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"USO DE TEXAFIRINA NA PREPARAçãO DE UM MEDICAMENTO PARA USO EM DIAGNóSTICO E TERAPIA OCULAR" é proporcionado o uso de texafirina para diagnóstico e terapia ocular, especialmente o uso de texafirina fotosensitiva para terapia fotodinâmica das condições do olho, caracterizadas por vasculatura anormal, tal como por exemplo, degeneração macular, ou pterígio. A texafirina fotosensitiva pode ser uma texafirina de base livre ou pode ser uma metalizada com um metal diamagnético. de preferência a texafirina fotosensitiva é metalizada com lutécio. Em virtude da dupla absorção de comprimento de onda das texafirinas, isto é, a 400 - 500 nm e a 700 - 800 nm, especialmente cerca de 732 nm, em comparação com as porfirinas, as texafirinas são mais eficientes e versáteis para uso em seres humanos em comparação às porfirinas. As texafirinas funcionam como agentes de contrastes efetivos na angiografia ocular.
BR9714642-0A 1996-12-11 1997-12-11 "uso de texafirina na preparação de um medicamento para uso em diagnóstico e terapia ocular" BR9714642A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76345196A 1996-12-11 1996-12-11
PCT/US1997/022661 WO1998025648A2 (en) 1996-12-11 1997-12-11 Use of a texaphyrin in ocular diagnosis and therapy

Publications (1)

Publication Number Publication Date
BR9714642A true BR9714642A (pt) 2000-10-03

Family

ID=25067866

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714642-0A BR9714642A (pt) 1996-12-11 1997-12-11 "uso de texafirina na preparação de um medicamento para uso em diagnóstico e terapia ocular"

Country Status (12)

Country Link
EP (1) EP1005369B1 (pt)
JP (1) JP2002512594A (pt)
KR (1) KR20000057532A (pt)
CN (1) CN1265039A (pt)
AT (1) ATE240745T1 (pt)
AU (1) AU730074B2 (pt)
BR (1) BR9714642A (pt)
CA (1) CA2278937A1 (pt)
DE (1) DE69722263T2 (pt)
IL (1) IL130246A0 (pt)
NZ (1) NZ336113A (pt)
WO (1) WO1998025648A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270749B1 (en) 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
US6280703B1 (en) * 1997-03-13 2001-08-28 Mallinckrodt Inc. Simultaneous multimodal measurement of physiological function
US6178346B1 (en) 1998-10-23 2001-01-23 David C. Amundson Infrared endoscopic imaging in a liquid with suspended particles: method and apparatus
US6443976B1 (en) * 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
US6319273B1 (en) * 1999-12-16 2001-11-20 Light Sciences Corporation Illuminating device for treating eye disease
ATE406914T1 (de) * 2000-02-10 2008-09-15 Massachusetts Eye & Ear Infirm Photodynamische therapie zur behandlung von augenerkrankungen
US7073510B2 (en) 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
US8215314B2 (en) 2000-02-11 2012-07-10 The General Hospital Corporation Photochemical tissue bonding
KR20020060020A (ko) * 2001-01-09 2002-07-16 박종윤 고출력 반도체 레이저 다이오드(high power semiconductorlaser diode)를 이용한 광역동 치료 및 진단(photodynamictreatment / diagnosis)용 의료용 레이저 기구
EP1617756A1 (en) * 2003-05-01 2006-01-25 Millennium Diet and Nutriceuticals Limited Measurement of distribution of macular pigment
US20060021623A1 (en) 2004-07-30 2006-02-02 Miller Joan W Methods and compositions for treating ocular glaucoma
US7468434B2 (en) * 2004-12-22 2008-12-23 The University Of Hong Kong Diazene-bridge crown ether lithium compounds and methods for their use
AU2007269609B2 (en) 2006-07-06 2012-09-13 Board Of Regents Of The University Of Nebraska Polychromatic, diversely-sized particles for angiography
RU2387471C1 (ru) * 2008-08-12 2010-04-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ количественной оценки эффективности фотодинамической терапии хориоидальной неоваскуляризации
RU2395318C1 (ru) * 2009-01-15 2010-07-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения скрытых субретинальных неоваскулярных мембран
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料
KR101894150B1 (ko) * 2016-11-15 2018-08-31 포항공과대학교 산학협력단 다광자 특성을 이용한 안과용 진단 및 치료장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
WO1995024930A1 (en) * 1994-03-14 1995-09-21 Massachusetts Eye & Ear Infirmary Use of green porphyrins in ocular diagnosis and therapy
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
AU717193B2 (en) * 1996-03-26 2000-03-23 Pharmacyclics, Inc. Use of a texaphyrin in photodynamic therapy of pigment-related lesions
AU727138B2 (en) * 1996-06-04 2000-12-07 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins

Also Published As

Publication number Publication date
CA2278937A1 (en) 1998-06-18
DE69722263D1 (de) 2003-06-26
AU730074B2 (en) 2001-02-22
DE69722263T2 (de) 2004-04-08
NZ336113A (en) 2000-12-22
EP1005369A2 (en) 2000-06-07
ATE240745T1 (de) 2003-06-15
JP2002512594A (ja) 2002-04-23
IL130246A0 (en) 2000-06-01
CN1265039A (zh) 2000-08-30
WO1998025648A2 (en) 1998-06-18
WO1998025648A3 (en) 1999-12-09
EP1005369B1 (en) 2003-05-21
KR20000057532A (ko) 2000-09-25
AU5897698A (en) 1998-07-03

Similar Documents

Publication Publication Date Title
BR9714642A (pt) "uso de texafirina na preparação de um medicamento para uso em diagnóstico e terapia ocular"
AR004422A1 (es) Uso de un compuesto fotoactivo para la manufactura de una composicion farmaceutica para mejorar la agudeza visual
BR0107705A (pt) Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva
NO993393D0 (no) Fotokjemoterapeutiske blandinger
IL158032A (en) Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostics
ES2020032A6 (es) Procedimiento de obtencion de composiciones oftalmicas a base de ciclosporina.
CA2536069A1 (en) Use of green porphyrins in ocular diagnosis and therapy
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
Johnson et al. Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration
BR0005222A (pt) Dispositivo para fixação rápida de travessas a pares de montantes, em particular, pares de pernas de cadeiras, mesas e similares
Ishiguro et al. Effect of near-infrared light-emitting diodes on nerve regeneration
BR9915951A (pt) Processo para preparação de uma composição farmacêutica para uso como um medicamento antiarritmias com um bloqueio beta adrenérgico controlado, composição farmacêutica, preparação oral e parenteral para tratamento de doenças cardìacas em mamìferos, e, método de tratamento para as mesmas
PT1267931E (pt) Derivados de rodamina para o diagnostico e tratamento fotodinamicos
DK178188A (da) Antivirusmiddel
BRPI0417474A (pt) compostos para o tratamento de ressecamento da superfìcie ocular causado por cirurgia fotorrefrativa
RU96121849A (ru) Способ лечения амблиопии
Veien et al. Photodynamic inactivation of verrucae vulgares. II
SE8901149D0 (sv) Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
BR9707303A (pt) Agentes terapêuticos para asma
WO2001022976A3 (en) Combination of a statin and ex-vivo treated blood for treating artheroclerosis
Chang et al. The clinical manifestations and treatments of parafoveal telangiectasis
SUN Laser photocoagulation for the treatment of retinal periphlebitis
KIM et al. Clinical effect of Nd-YAG synechiolysis
ROH et al. The role of preoperative indirect ophthalmoscopy under general anesthesia for diagnosis of torsional strabismus
MX9405380A (es) Benzotiofenos y benzofuranos como agentes de uso terapeutico en eltratamiento de enfermedades inflamatorias del intestino y metodos contrala inflamacion.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1835 DE 07/03/2006.